Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 17, 1985 - Issue 2
Submit an article Journal homepage
16
Views
86
CrossRef citations to date
0
Altmetric
Main Article

Intravenous Foscarnet for the Treatment of Severe Cytomegalovirus Infection in Allograft Recipients

Göran Klintmalm Department of Transplantation Surgery, Huddinge Hospital, Karolinska Institute, Stockholm, Sweden
,
Berit Lönnqvist Division of Clinical Hematology and Oncology, Department of Internal Medicine, Huddinge Hospital, Karolinska Institute, Stockholm, Sweden
,
Bo Öberg Astra Läkemedel AB, Södertälje National Bacteriological Laboratory, Stockholm, Sweden
,
Gösta Gahrton Division of Clinical Hematology and Oncology, Department of Internal Medicine, Huddinge Hospital, Karolinska Institute, Stockholm, Sweden
,
John-Olof Lernestedt Astra Läkemedel AB, Södertälje National Bacteriological Laboratory, Stockholm, Sweden
,
Göran Lundgren Department of Transplantation Surgery, Huddinge Hospital, Karolinska Institute, Stockholm, Sweden
,
Olle Ringdén Department of Transplantation Surgery, Huddinge Hospital, Karolinska Institute, Stockholm, Sweden
,
Karl-Henrik Robert Division of Clinical Hematology and Oncology, Department of Internal Medicine, Huddinge Hospital, Karolinska Institute, Stockholm, Sweden
,
Britta Wahren Department of Virology, National Bacteriological Laboratory, Stockholm, Sweden
&
Carl-Gustav Groth Department of Transplantation Surgery, Huddinge Hospital, Karolinska Institute, Stockholm, Sweden
 show all
Pages 157-163 | Published online: 02 Jan 2015

References

  • . Nieman PE, Reeves W, Ray G, Flournoy N, Lerner KG, Sale GE, Thomas ED. A prospective analysis of interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone-marrow grafts. J Infect Dis 136: 754–767, 1977.
  • . Simmons RL, Matas AJ, Rattazzi LC, Balfour HHJ, Howard RJ, Najarian JS. Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery 82: 537–546, 1977.
  • . Chattarjee SN, Jordan GW. Prospective study of the prevalence and symptomatology of cytomegalovirus infection in renal transplant recipients. Transplantation 28: 457–460, 1979.
  • . Marker SC, Howard RJ, Simmons RL, Kalis JM, Conelly DP, Najarian JS, Balfour HHJ. Cytomegalovirus infection: A quantitative prospective study of three hundred-twenty consecutive renal transplants. Surgery 89: 660–671, 1981.
  • . Ashraf MH, Campalani GC, Qureshi SA, Froud DJ, Yacoub MH. Acyclovir in the treatment of cytomegalovirus pneumonia after cardiac transplantation. Lancet 1: 173–174, 1982.
  • . Gadler H, Tillegård A, Groth GG. Studies of cytomegalovirus infection in renal allograft recipients. 1. Virus isolation. Scand J Infect Dis 14: 81–87, 1982.
  • . Meyers JD, Flournoy N, Thomas ED. Non-bacterial pneumonia after allogeneic marrow transplantation: A review often years' experience. Rev Infect Dis 4: 1119–1132, 1982.
  • . Wade JC, Hintz M, McGuffin RW, Springmeyer SC, Connor JD, Meyers JD. Treatment of cytomegalovirus pneumonia with high-dose acyclovir. Am J Med 73 (Suppl.): 249–256, 1982.
  • . Ch'ien LT, Cannon NJ, Whitley RJ, Diethelm AG, Dismukes WE, Scott CW, Buchanan RA, Alford CA Jr. Effects of adeninine arabinoside on cytomegalovirus infections. J Infect Dis 130: 32–39, 1974.
  • . Cheeseman SH, Rubin RH, Stewart JA, Tolkoff-Rubin NE, Cosimi AB, Cantell K, Gilbert J, Winkle S, Herrin JT, Black PH, Russell PS, Hirsch MS. Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infection. N Engl J Med 300: 1345–1349, 1979.
  • . Meyers JD, McGuffin RW, Nieman PE, Singer JW, Thomas ED. Toxicity and efficacy of human leukocyte interferon for the treatment of cytomegalovirus pneumonia after marrow transplantation. J Infect Dis 141: 555–562, 1980.
  • . Meyers JD, McGuffin RW, Bryson YJ, Cantell K, Thomas ED. Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon. J Infect Dis 146: 80–84, 1982.
  • . Helgstrand E, Eriksson B, Johansson NG, Lannerö B, Larsson A, Misiorny A, Noren JO, Sjöberg B, Stenberg K, Stening G, Stridh S, Öberg B, Alenius S, Philipson L. Trisodium phosphonoformate, a new antiviral compound. Science 201: 819–821, 1978.
  • . Öberg B. Antiviral effects of phosphonoformate (PFA, foscarnet sodium). Pharmacol Ther 19: 387–415, 1983.
  • . Eriksson B, Öberg B, Wahren B. Pyrophosphate analogues as inhibitors of DNA polymerases of cytomegalovirus, herpes simplex virus and cellular origin. Biochim Biophys Acta 696: 115–123, 1982.
  • . Wahren B, Öberg B. Inhibition of cytomegalovirus late antigens by phosphonoformate. Intervirology 12: 335–339, 1979.
  • . Wahren B, Öberg B. Reversible inhibition of cytomegalovirus replication by phosphonoformate. Intervirology 14: 7–15, 1980.
  • . Wallin J, Lernestedt JO, Lycke E. Treatment of recurrent herpes labialis with trisodium phosphonoformate. In: Nelson JD, Grassi C, eds. Current chemother and infectious diseases. Washington, D.C.: American Society for Microbiology, vol. 2: 1361–1362, 1980.
  • . Wallin J, Lycke E, Lernestedt JO, Ogenstad S. Foscarnet in the treatment of recurrent genital herpes. Scand J Infect Dis 17: 165–172, 1985.
  • . Ringdén O, Ost L, Klintmalm G, Tillegård A, Fehrman I, Wilczek H, Groth CG. Improved outcome in renal transplant recipients above 55 years of age treated with cyclosporine A and low doses of steroids. Transpl Proc 15: 291–296, 1983.
  • . Ringdén O, Lönnqvist B, Lundgren G, Gahrton G, Groth CG, Möller E, Båryd I, Johansson B, Pihlstedt P, Gullbring B. Experience with a cooperative bone-marrow transplantation program in Stockolm. Transplantation 33: 500–504, 1982.
  • . Sundqvist VA, Wahren B. An interchangable ELISA for cytomegalovirus antigen and antibody. J Virol Methods 2: 301–312, 1981.
  • . Wahren B, Wahren P, Harmenberg J, Sundqvist VA. Computer based virus sensitivity assay and neutralization method. J Virol Methods 6: 271–282, 1983.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.